One potential explanation of dysregulation in patients with PTSD is decreased plasma cortisol levels, increased CRH activity, and increased sensitivity of the glucocorticoid receptors in PTSD patients as compared to controls [9, 11, 12], though results have been mixed. This evidence concerns the gene NR3C1 and post-traumatic stress disorder.